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Abstract Candida is one of the leading causes of sepsis,
and an effective host immune response to Candida critically
depends on the cytokines IL-1β and IL-18, which need
caspase-1 cleavage to become bioactive. Caspase-12 has
been suggested to inhibit caspase-1 activation and has been
implicated as a susceptibility factor for bacterial sepsis. In
populations of African descent, CASP ASE-12 is either
functional or non-functional. Here, we have assessed the
frequencies of both CASP ASE-12 alleles in an African-
American Candida sepsis patients cohort compared to
uninfected patients with similar predisposing factors.
African-American Candida sepsis patients (n=93) and
non-infected African-American patients (n=88) were gen-
otyped for the CASP ASE-12 genotype. Serum cytokine
concentrations of IL-6, IL-8, and IFNγ were measured in
the serum of infected patients. Statistical comparisons were
performed in order to assess the effect of the CASP ASE-12
genotype on susceptibility to candidemia and on serum
cytokine concentrations. Our findings demonstrate that
CASP ASE-12 does not influence the susceptibility to
Candida sepsis, nor has any effect on the serum cytokine
concentrations in Candida sepsis patients during the course
of infection. Although the functional CASP ASE-12 allele
has been suggested to increase susceptibility to bacterial
sepsis, this could not be confirmed in our larger cohort of
fungal sepsis patients.
Introduction
One of the leading pathogens causing sepsis in immuno-
compromised hosts are Candida spp. [1, 2]. Medical
conditions that lead to an immunocompromised state
increase susceptibility to Candida sepsis [3]. In addition
to exogenous factors, it is believed that genetic variation
also plays an important role in susceptibility to sepsis [4–
6]. Caspase-12 is an inflammatory caspase, in which a loss-
of-function genetic variant has been fixed in some
populations by still undefined evolutionary pressures [7–
9]. This loss-of-function is due to the presence of a T/C
single nucleotide polymorphism (rs497116) on nucleotide
position 125 in the CASP ASE-12 gene [10]. Although the
ancestral variant is still present in African and African-
American populations, of which 20–30% express the active
D. C. Rosentul:T. S. Plantinga (*): N. M. D. van de Geer:
B. J. Kullberg:M. G. Netea
Department of Medicine,
Radboud University Nijmegen Medical Centre,
Internal postal code 463, P .O. Box 9101, Geert Grooteplein 8,
6500 HB Nijmegen, The Netherlands
e-mail: t.plantinga@aig.umcn.nl
D. C. Rosentul:T. S. Plantinga: N. M. D. van de Geer:
B. J. Kullberg:M. G. Netea
Nijmegen Institute for Infection,
Inflammation and Immunity (N4i), Radboud University Nijmegen
Medical Centre,
P .O. Box 9101, 6500 HB Nijmegen, The Netherlands
W. K. Scott
Dr. John T. Macdonald Foundation Department of Human
Genetics and John P . Hussman Institute for Human Genomics,
University of Miami, Miller School of Medicine,
Miami, FL 33136, USA
B. D. Alexander:J. R. Perfect: M. D. Johnson
Duke University Medical Centre,
Durham, NC 27708, USA
M. D. Johnson
Department of Clinical Research,
Campbell University School of Pharmacy,
Buies Creek, NC 27506, USA
ARTICLE
The impact of caspase-12 on susceptibility to candidemia
D. C. Rosentul & T. S. Plantinga & W. K. Scott &
B. D. Alexander & N. M. D. van de Geer & J. R. Perfect &
B. J. Kullberg & M. D. Johnson & M. G. Netea
Received: 9 February 2011 /Accepted: 24 May 2011 /Published online: 25 June 2011
# The Author(s) 2011. This article is published with open access at Springerlink.com
Eur J Clin Microbiol Infect Dis (2012) 31:277–280
DOI 10.1007/s10096-011-1307-xvariant of caspase-12, it is absent in Asian and Caucasian
populations [9, 10].
Functional studies have suggested that functional
caspase-12 is a negative regulator of caspase-1 activation,
which might result in less cytokine production in response
to recognition through pattern recognition receptors. Thus,
based on the proposed inhibitory effect on caspase-1 and,
consequently, lower IL-1β and IL-18 production, functional
caspase-12 may increase the susceptibility to severe sepsis
and/or the clinical outcome of sepsis patients [10].
Therefore, it is compelling to assess whether genetic
variation in CASP ASE-12 plays a role in the susceptibility
to Candida sepsis. The aim of this study was to assess
whether genetic variants of CASP ASE-12 influence the
incidence, severity, and mortality of Candida sepsis in a
cohort of African-American patients.
Patients, materials, and methods
Subjects were enrolled between January 2003 and January
2009 after informed consent (or waiver, as approved by the
Institutional Review Board) at the Duke University Hospi-
tal (DUMC, Durham, NC, USA). Infected subjects had ≥1
positive blood cultures for a Candida species while
hospitalized. Non-infected controls were recruited from
the same hospital wards as infected patients, with no history
or evidence of Candida sepsis/invasive candidiasis or any
invasive fungal infection.
Genomic DNA was isolated from whole blood using
standard procedures. The region of interest of the CAS-
P ASE-12 gene was amplified as described previously [10].
Circulating cytokine concentrations of IL-6, IL-8, and
IFNγ in infected patients were measured by Multiplex
Fluorescent Bead Immunoassays (xMAP technology, Bio-
Rad, V eenendaal, the Netherlands), from day 0 up to day 5
after the initial positive blood culture.
Statistical comparisons of frequencies were made
between infected versus non-infected subjects using
Chi-square tests. Statistical analysis of the cytokine data
was performed by using the Mann–Whitney U-test.
Overall, a p-value<0.05 was considered to be statistically
significant.
Results
A total of 93 African-American patients and 88 non-
infected African-American controls had genetic and clinical
data available for the analysis. The demographic data for
the study subjects are presented in Table 1.
No significant differences in the distribution of CAS-
P ASE-12 genotypes were seen when comparing infected
patients (CC 3.9%, CT 25.3%, TT 72.4%) and non-infected
controls (CC 2.9%, CT 30.0%, TT 66.1%) (p>0.05). No
associations between the CASP ASE-12 genotypes and
disseminated disease, persistent fungemia, or 30-day mor-
tality were observed (data not shown).
Serum samples collected from infected patients during
the first 5 days after the initial positive blood culture were
measured for concentrations of IL-6, IL-8, and IFNγ. Also,
measurements of IL-1β and IL-18 were performed in these
samples. However, the concentrations of these cytokines
were too low to detect (data not shown). Cytokine
concentrations decreased over time. No differences in
Table 1 Baseline patient characteristics of African-American patients
with Candida systemic infection or uninfected controls recruited at the
Duke University Hospital (DUMC, Durham, NC, USA) (n=181)
V ariable Infected
cohort
(n=93), %
Control
cohort
(n=88), %
Mean age (years) 52 52
Gender
Male 51.6 48.9
Family 48.4 51.1
Immunocompromised state 54.8 48.9
HSCT 0 0
Solid organ transplant 7.5 3.5
Active malignancy* 22.6 13.8
Solid tumor 14 8.0
Leukemia 5.4 3.5
Lymphoma 3.2 2.3
Chemotherapy within past 3 months 12.9 5.6
Neutropenia (ANC <500 cells/mm
3) 4.3 1.2
HIV-infected 5.4 0
Surgery within past 30 days 34.4 30.7
Receipt of total parenteral nutrition 19.4 5.75
Dialysis-dependent 15.1 8.0
Acute renal failure 36.6 33.0
Liver failure 25.8 1.2
Intensive care unit admission within the
past 14 days
39.8 31.8
Median baseline serum creatinine (mg/dL) 2.27 1.9
Median baseline WBC count (cells/mm
3) 13.0 10.87
Candida spp.**
albicans 44.2 –
glabrata 23.7
parapsilosis 17.2
tropicalis 10.8
krusei 3.2
Other Candida spp. 0.9
*Subjects could have more than one active malignancy
**Sixteen subjects had >1 species isolated
278 Eur J Clin Microbiol Infect Dis (2012) 31:277–280cytokine concentrations were apparent between individuals
bearing different CASP ASE-12 genotypes (Fig. 1).
Discussion
Caspase-12 has been suggested to inhibit caspase-1 process-
ing of proIL-1β and proIL-18 into the active cytokines.
Genetic variation of CASP ASE-12 in populations of African
descent has been previously associated with susceptibility to
bacterial sepsis [10]. The present study was performed in
order to assess the role of caspase-12 in sepsis caused by
Candida spp. The results indicate that the CASP ASE-12
genotype has no significant effect on the susceptibility and
severity of systemic infections with Candida.
Candida is one of the leading pathogens causing sepsis
[2, 11, 12]. Pro-inflammatory cytokines such as IL-1β and
IL-18 are a crucial factor in eliciting an effective immune
response to eradicate the infection. A modulatory step in
the production of these cytokines is exerted at the level of
caspase-1, a protease that cleaves the pro-form of these
cytokines into shorter bioactive proteins [13, 14]. It has
previously been reported that CASP ASE-12 knockout mice
were better capable of clearing both local and systemic
bacterial infections compared to wild-type mice, through an
improved inflammatory response [15]. The same authors
described a similar effect of caspase-12 in patients with
bacterial sepsis, with individuals bearing functional
caspase-12 being more susceptible to this condition [10].
However, the role of CASP ASE-12 genetic variants in fungal
sepsis has not been addressed so far.
Firstly, the comparison of CASP ASE-12 genotype fre-
quencies in African-American patients with non-infected
controls revealed no statistically significant differences.
Secondly, no effects of the CASP ASE-12 genotype was
observed in relation to the clinical outcome of infection,
assessed as disseminated disease, persistent fungemia, and
30-day mortality. Furthermore, serum cytokine concentra-
tions during the first 5 days of infection were shown to be
unaffected by the CASP ASE-12 genotype.
Our findings on the lack of influence of the CASP ASE-12
genotype on fungal sepsis contrast with those of Saleh et al.
[10, 15], who suggested an important role of this genetic
variant in bacterial sepsis. Moreover, circulating cytokine
concentrations in infected patients were also not influenced
by the CASP ASE-12 genotype. It should be emphasized that
this is, in particular, true for IL-6 and IFNγ, cytokines that
are induced by IL-1β and IL-18, respectively [16–18]. This
provides indirect evidence that functional caspase-12 has no
clear effect on the production of IL-1β and IL-18 in the
context of Candida sepsis. One possible explanation for the
discrepancy between this study and that of Saleh et al. [10]
is represented by the different cause of sepsis in the two
studies, fungal and bacterial, respectively. However, one has
to concede that the pro-inflammatory cytokines, of which
production is reportedly regulated by the CASP ASE-12
genotype, exert similar protective effects in bacterial and
fungal sepsis [18–21]. In this respect, a recent study has
also failed to reproduce the inhibitory effects of the
CASP ASE-12 genotype of lipopolysaccharide and Gram-
Fig. 1 IL-6, IL-8, and IFNγ circulating concentrations in infected
patients from day 0 up to day 5 after initial positive blood culture, in
relation to the CASP ASE-12 genotype. TC heterozygous, TT homozy-
gous mutant. The data are presented as mean±standard error of the
mean (SEM)
Eur J Clin Microbiol Infect Dis (2012) 31:277–280 279negative bacteria-induced cytokine production [22], bring-
ing into question the biological activity of caspase-12.
In conclusion, although an effect of the CASP ASE-12
genotype on the susceptibility to bacterial sepsis has been
previously reported in a small cohort of African-American
patients [10], this could not be confirmed in our larger
cohort of fungal sepsis patients. Furthermore, clinical
outcome and in vivo cytokine responses were not influence
by the CASP ASE-12 genotype. Therefore, we propose that
caspase-12 is redundant for systemic host defense in sepsis.
Acknowledgments D.C.R. was funded by the European Commission
through the FINSysB Marie Curie Initial Training Network (PITN-GA-
2008-214004). This study was partially supported by a Vici grant from
the Netherlands Organisation for Scientific Research (NWO) to M.G.N.,
and NIH grants AI-51537 to M.D.J. and AI-73896 to J.R.P .
Conflict of interest All authors declare no conflicts of interest.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Pfaller MA, Diekema DJ (2007) Epidemiology of invasive
candidiasis: a persistent public health problem. Clin Microbiol
Rev 20:133–163
2. Gudlaugsson O, Gillespie S, Lee K, V ande Berg J, Hu J, Messer S,
Herwaldt L, Pfaller M, Diekema D (2003) Attributable mortality of
nosocomial candidemia, revisited. Clin Infect Dis 37:1172–1177
3. Eggimann P , Garbino J, Pittet D (2003) Epidemiology of Candida
species infections in critically ill non-immunosuppressed patients.
Lancet Infect Dis 3:685–702
4. Khor CC, Chapman SJ, V annberg FO, Dunne A, Murphy C, Ling
EY , Frodsham AJ, Walley AJ, Kyrieleis O, Khan A, Aucan C,
Segal S, Moore CE, Knox K, Campbell SJ, Lienhardt C, Scott A,
Aaby P , Sow OY , Grignani RT, Sillah J, Sirugo G, Peshu N,
Williams TN, Maitland K, Davies RJ, Kwiatkowski DP , Day NP ,
Yala D, Crook DW, Marsh K, Berkley JA, O'Neill LA, Hill A V
(2007) A Mal functional variant is associated with protection
against invasive pneumococcal disease, bacteremia, malaria and
tuberculosis. Nat Genet 39:523–528
5. Lorenz E, Mira JP , Frees KL, Schwartz DA (2002) Relevance of
mutations in the TLR4 receptor in patients with gram-negative
septic shock. Arch Intern Med 162:1028–1032
6. Sutherland AM, Walley KR, Russell JA (2005) Polymorphisms in
CD14, mannose-binding lectin, and Toll-like receptor-2 are
associated with increased prevalence of infection in critically ill
adults. Crit Care Med 33:638–644
7. Eckhart L, Ballaun C, Hermann M, V andeBerg JL, Sipos W,
Uthman A, Fischer H, Tschachler E (2008) Identification of novel
mammalian caspases reveals an important role of gene loss in
shaping the human caspase repertoire. Mol Biol Evol 25:831–841
8. Yngvadottir B, Xue Y , Searle S, Hunt S, Delgado M, Morrison J,
Whittaker P , Deloukas P , Tyler-Smith C (2009) A genome-wide
survey of the prevalence and evolutionary forces acting on human
nonsense SNPs. Am J Hum Genet 84:224–234
9. Xue Y , Daly A, Yngvadottir B, Liu M, Coop G, Kim Y , Sabeti P ,
Chen Y , Stalker J, Huckle E, Burton J, Leonard S, Rogers J, Tyler-
Smith C (2006) Spread of an inactive form of caspase-12 in
humans is due to recent positive selection. Am J Hum Genet
78:659–670
10. Saleh M, V aillancourt JP , Graham RK, Huyck M, Srinivasula SM,
Alnemri ES, Steinberg MH, Nolan V , Baldwin CT, Hotchkiss RS,
Buchman TG, Zehnbauer BA, Hayden MR, Farrer LA, Roy S,
Nicholson DW (2004) Differential modulation of endotoxin
responsiveness by human caspase-12 polymorphisms. Nature
429:75–79
11. Martin GS, Mannino DM, Eaton S, Moss M (2003) The
epidemiology of sepsis in the United States from 1979 through
2000. N Engl J Med 348:1546–1554
12. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP ,
Edmond MB (2004) Nosocomial bloodstream infections in US
hospitals: analysis of 24,179 cases from a prospective nationwide
surveillance study. Clin Infect Dis 39:309–317
13. Martinon F, Tschopp J (2004) Inflammatory caspases: linking an
intracellular innate immune system to autoinflammatory diseases.
Cell 117:561–574
14. Fantuzzi G, Dinarello CA (1999) Interleukin-18 and interleukin-1
beta: two cytokine substrates for ICE (caspase-1). J Clin Immunol
19:1–11
15. Saleh M, Mathison JC, Wolinski MK, Bensinger SJ, Fitzgerald P ,
Droin N, Ulevitch RJ, Green DR, Nicholson DW (2006)
Enhanced bacterial clearance and sepsis resistance in caspase-12-
deficient mice. Nature 440:1064–1068
16. Tosato G, Jones KD (1990) Interleukin-1 induces interleukin-6
production in peripheral blood monocytes. Blood 75:1305–
1310
17. Zhang YH, Lin JX, Vilcek J (1990) Interleukin-6 induction by
tumor necrosis factor and interleukin-1 in human fibroblasts
involves activation of a nuclear factor binding to a kappa B-like
sequence. Mol Cell Biol 10:3818–3823
18. Netea MG, Stuyt RJ, Kim SH, V an der Meer JW, Kullberg BJ,
Dinarello CA (2002) The role of endogenous interleukin (IL)-18,
IL-12, IL-1beta, and tumor necrosis factor-alpha in the production
of interferon-gamma induced by Candida albicans in human
whole-blood cultures. J Infect Dis 185:963–970
19. Mencacci A, Bacci A, Cenci E, Montagnoli C, Fiorucci S,
Casagrande A, Flavell RA, Bistoni F, Romani L (2000) Interleukin
18 restores defective Th1 immunity to Candida albicans in
caspase 1-deficient mice. Infect Immun 68:5126–5131
20. Hultgren OH, Svensson L, Tarkowski A (2002) Critical role of
signaling through IL-1 receptor for development of arthritis and
sepsis during Staphylococcus aureus infection. J Immunol
168:5207–5212
21. Bohn E, Sing A, Zumbihl R, Bielfeldt C, Okamura H, Kurimoto
M, Heesemann J, Autenrieth IB (1998) IL-18 (IFN-gamma-
inducing factor) regulates early cytokine production in, and
promotes resolution of, bacterial infection in mice. J Immunol
160:299–307
22. Ferwerda B, McCall MB, de Vries MC, Hopman J, Maiga B, Dolo
A, Doumbo O, Daou M, de Jong D, Joosten LA, Tissingh RA,
Reubsaet FA, Sauerwein R, van der Meer JW, van der V en AJ,
Netea MG (2009) Caspase-12 and the inflammatory response to
Yersinia pestis. PLoS One 4:e6870
280 Eur J Clin Microbiol Infect Dis (2012) 31:277–280